Deep Bio (딥바이오)

Ansan-si, South Korea

Diagnostics Clinical Diagnostics Biotech

Deep Bio (딥바이오) is dedicated to improving the reliability and decreasing the turnaround time of medical diagnoses. Deep Bio is currently collaborating with medical professionals in integrating artificial intelligence (AI) into existing clinical workflows to help them make better-informed decisions that will lead to the best outcomes for patients. Deep Bio aims to improve and optimize diagnostic processes, and make quality healthcare more accessible for patients across the globe.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Deep Bio (딥바이오) on @MedStartr Today #Diagnostics #ImprovingDiagnostics #ClinicalDiagnostics #Biotech #MedMo #MedStartrVentures

https://www.medstartr.ai/s/AfZN3R7jICc

Get Involved in Deep Bio (딥바이오)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2015
Website: deepbio.co.kr/

Disease Areas

Diagnostics Improving Diagnostics

Technologies

DiagnosticsData Analysis

🌐Website

What do you think of Deep Bio (딥바이오)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.